halothane has been researched along with sotalol in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Bergamaschi, M; Caravaggi, AM; Mandelli, V; Shanks, RG | 1 |
| Awaji, T; Haruno, A; Hashimoto, K; Hirasawa, A; Wu, Z; Xue, Y | 1 |
| Antzelevitch, C; Nesterenko, VV; Weissenburger, J | 1 |
| Hashimoto, K; Sugiyama, A; Takahara, A | 2 |
| Akie, Y; Hashimoto, K; Sakaguchi, Y; Sugiyama, A; Takahara, A; Takao, S | 1 |
| Ito, S; Kimura, K; Nakamura, M; Tabo, M | 1 |
| Ishizaka, T; Iwasaki, H; Kise, H; Mitsumori, Y; Nakamura, Y; Sugiyama, A; Takahara, A | 1 |
| Akie, Y; Nakamura, Y; Sakaguchi, Y; Sugiyama, A; Takahara, A | 1 |
| Ando, K; Cao, X; Honda, A; Izumi-Nakaseko, H; Katagi, J; Nakamura, Y; Ohara, H; Sugiyama, A | 1 |
| Akie, Y; Ando, K; Hoshiai, K; Izumi-Nakaseko, H; Nagayama, Y; Nakamura, Y; Saito, H; Sugiyama, A; Wada, T; Yokoyama, H | 1 |
| Akie, Y; Goto, A; Hagiwara-Nagasawa, M; Hoshiai, K; Izumi-Nakaseko, H; Kambayashi, R; Kawai, S; Matsumoto, A; Nunoi, Y; Saito, H; Sugiyama, A; Takei, Y | 1 |
15 other study(ies) available for halothane and sotalol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
The role of beta adrenoceptors in the coronary and systemic hemodynamic responses to emotional stress in conscious dogs.
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Acids; Anesthesia, Intravenous; Animals; Blood Flow Velocity; Blood Pressure; Cardiac Output; Catheterization; Coronary Circulation; Dogs; Electrocardiography; Emotions; Halothane; Heart Rate; Hemodynamics; Humans; Propranolol; Propylamines; Receptors, Adrenergic; Respiration, Artificial; Sotalol; Stress, Psychological; Thiopental | 1973 |
Effects of the new class III antiarrhythmic drug MS-551 and d-sotalol on canine coronary ligation-reperfusion ventricular arrhythmias.
Topics: Animals; Anti-Arrhythmia Agents; Dogs; Female; Halothane; Ligation; Male; Myocardial Reperfusion; Pentobarbital; Pyrimidinones; Sotalol; Ventricular Fibrillation | 1995 |
Transmural heterogeneity of ventricular repolarization under baseline and long QT conditions in the canine heart in vivo: torsades de pointes develops with halothane but not pentobarbital anesthesia.
Topics: Action Potentials; Anesthesia, General; Anesthetics, Inhalation; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dogs; Drug Interactions; Electrocardiography; Female; Halothane; Heart Rate; Heart Ventricles; Hypnotics and Sedatives; Long QT Syndrome; Male; Myocardium; Pentobarbital; Sotalol; Torsades de Pointes | 2000 |
Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation.
Topics: Action Potentials; Adrenergic beta-Antagonists; Algorithms; Anesthetics, Inhalation; Animals; Chromans; Delayed Rectifier Potassium Channels; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Guinea Pigs; Halothane; Heart; Heart Conduction System; Heart Ventricles; Histamine H1 Antagonists; Linear Models; Long QT Syndrome; Male; Models, Animal; Pharmaceutical Preparations; Potassium Channel Blockers; Reproducibility of Results; Sotalol; Sulfonamides; Terfenadine; Time Factors | 2005 |
Halothane sensitizes the guinea-pig heart to pharmacological IKr blockade: comparison with urethane anesthesia.
Topics: Action Potentials; Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Chromans; Delayed Rectifier Potassium Channels; Drug Evaluation, Preclinical; Electrocardiography; Guinea Pigs; Halothane; Heart Rate; Male; Potassium; Potassium Channel Blockers; Sotalol; Sulfonamides; Time Factors; Urethane | 2005 |
Characterization of the halothane-anesthetized guinea-pig heart as a model to detect the K+ channel blocker-induced QT-interval prolongation.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Anti-Arrhythmia Agents; Chromans; Electrocardiography; Guinea Pigs; Halothane; Heart; Heart Rate; Long QT Syndrome; Male; Potassium Channel Blockers; Sotalol; Sulfonamides | 2006 |
QT-RR relationships and suitable QT correction formulas for halothane-anesthetized dogs.
Topics: Analysis of Variance; Anesthesia; Animals; Astemizole; Dogs; Electrocardiography; Halothane; Male; Propranolol; Sotalol | 2006 |
Comparison of electropharmacological effects of bepridil and sotalol in halothane-anesthetized dogs.
Topics: Adrenergic beta-Antagonists; Anesthetics, Inhalation; Animals; Atrioventricular Node; Bepridil; Bundle of His; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Female; Halothane; Heart Conduction System; Male; Models, Animal; Myocardial Contraction; Pacemaker, Artificial; Sinoatrial Node; Sotalol; Vasodilator Agents | 2008 |
Halothane-anaesthetized, closed-chest, guinea-pig model for assessment of drug-induced QT-interval prolongation.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Electrocardiography; Guinea Pigs; Halothane; Heart; Heart Rate; Long QT Syndrome; Male; Models, Animal; Sotalol; Verapamil | 2009 |
Why Can dl-Sotalol Prolong the QT Interval In Vivo Despite Its Weak Inhibitory Effect on hERG K(+) Channels In Vitro? Electrophysiological and Pharmacokinetic Analysis with the Halothane-Anesthetized Guinea Pig Model.
Topics: Anesthesia, Inhalation; Animals; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Electrocardiography; ERG1 Potassium Channel; Guinea Pigs; Halothane; Heart Rate; Male; Models, Animal; Sotalol | 2016 |
Pharmacological characterization of microminipig as a model to assess the drug-induced cardiovascular responses for non-clinical toxicity and/or safety pharmacology studies.
Topics: Adrenergic beta-Antagonists; Anesthesia; Anesthetics, Inhalation; Animals; Electrocardiography; Halothane; Long QT Syndrome; Male; Models, Animal; Sotalol; Swine; Swine, Miniature; Toxicity Tests | 2017 |
In vivo comparison of dl-sotalol-induced electrocardiographic responses among halothane anesthesia, isoflurane anesthesia with nitrous oxide, and conscious state.
Topics: Anesthesia; Animals; Consciousness; Dogs; Electrocardiography; Halothane; Isoflurane; Male; Nitrous Oxide; Sotalol | 2021 |